Adoptive transfer of DBY-specific TCR transgenic Marilyn T cells allows monitoring of tumor Ag-specific CD4+ T cell response, mimicking naive T cells that have exited the thymus and encounter tumor Ags in the TdLN. This evidence concerns the gene CD4 and neoplasm.